DEU/Saxony/Ebersbach The Saxon cannabis producer Demecan is now the first German company to be authorised to cultivate medicinal cannabis indefinitely under the new Cannabis Act. The company had been authorised to produce since 2019, albeit subject to conditions such as a maximum production quantity or regulated distribution. These conditions will now no longer apply, which will improve the supply situation for medicinal cannabis. The Federal Government Commissioner for Addiction and Drug Issues Burkhard Blienert and Health Minister Petra Köpping took a tour of the production facility to find out more about the production of medicinal cannabis., Federal Drug Commissioner Burghard Blienert and Health Minister Petra Köpping visit Saxon cannabis producer Demecan, Ebersbach, Saxony, Germany, Europe

DEU/Saxony/Ebersbach The Saxon cannabis producer Demecan is now the first German company to be authorised to cultivate medicinal cannabis indefinitely under the new Cannabis Act. The company had been authorised to produce since 2019, albeit subject to conditions such as a maximum production quantity or regulated distribution. These conditions will now no longer apply, which will improve the supply situation for medicinal cannabis. The Federal Government Commissioner for Addiction and Drug Issues Burkhard Blienert and Health Minister Petra Köpping took a tour of the production facility to find out more about the production of medicinal cannabis., Federal Drug Commissioner Burghard Blienert and Health Minister Petra Köpping visit Saxon cannabis producer Demecan, Ebersbach, Saxony, Germany, Europe
SuperStock offers millions of photos, videos, and stock assets to creatives around the world. This image of DEU/Saxony/Ebersbach The Saxon cannabis producer Demecan is now the first German company to be authorised to cultivate medicinal cannabis indefinitely under the new Cannabis Act. The company had been authorised to produce since 2019, albeit subject to conditions such as a maximum production quantity or regulated distribution. These conditions will now no longer apply, which will improve the supply situation for medicinal cannabis. The Federal Government Commissioner for Addiction and Drug Issues Burkhard Blienert and Health Minister Petra Köpping took a tour of the production facility to find out more about the production of medicinal cannabis., Federal Drug Commissioner Burghard Blienert and Health Minister Petra Köpping visit Saxon cannabis producer Demecan, Ebersbach, Saxony, Germany, Europe by Sylvio Dittrich/imageBROKER is available for licensing today.
$24.99
Personal Use
Personal Print and non commercial wall décor use. Not for re-sale.
$99.00
Website
Single non-exclusive Website, App, social media and blog use, for 5 years. Excludes Advertising.
$225.00
Magazines / Books / Educational
Non-exclusive Magazine, Book or Educational use, both print and digital, in any language. Worldwide in Perpetuity. Does not include cover use.
$300.00
Marketing Bundle
Single non exclusive use in a marketing campaign, worldwide (excludes advertising). Only available to companies with up to 20 employees for 5 years.
$440.00
Advertising Pack
Single Non exclusive use in Advertising Campaign up to 50,000 and digital copies, includes: brochure, catalog, flyer, newsletter, and other collateral printed pieces + web usage. Worldwide for 5 years.
  • Download your images from the download tab on this page after purchase.
  • Up to 3 downloads
  • Can be used for 365 days after purchase.
$59.99
RM Personal Print 3 Pack
Save $14.98
$20.00
per download
Order a Framed Print
Looking for a license?
Click here, and we'll help you find it! Questions? Just ask!
DETAILS
Image Number: 1848-61635371Rights ManagedCredit Line:Sylvio Dittrich/imageBROKER/SuperStockCollection:imageBROKERContributor:Sylvio DittrichModel Release:NoProperty Release:NoResolution:6000×4499
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|